Keltner D

UC Berkeley, Center for the Science of Psychedelics, University of California, Berkeley, Berkeley, USA.

2 papers · ORCID

ArticlePsychedelics

Well-being as a primary endpoint in clinical trials: a call for consensus.

Marseille E, Kettner H, Sgambati TJ +6

Europe PMC2026
ArticlePsychedelics

Awe as a Pathway to Mental and Physical Health.

Monroy M, Keltner D

Europe PMC2023